CME Group Inc. $CME Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 872,899 shares of the financial services provider’s stock after selling 23,635 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in CME Group were worth $228,682,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Brookmont Capital Management lifted its stake in shares of CME Group by 0.6% in the third quarter. Brookmont Capital Management now owns 5,661 shares of the financial services provider’s stock valued at $1,483,000 after purchasing an additional 34 shares during the period. Manchester Capital Management LLC raised its position in shares of CME Group by 2.9% in the third quarter. Manchester Capital Management LLC now owns 1,297 shares of the financial services provider’s stock valued at $340,000 after buying an additional 37 shares during the last quarter. NBT Bank N A NY increased its stake in CME Group by 2.3% in the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after purchasing an additional 38 shares during the last quarter. Resonant Capital Advisors LLC increased its position in shares of CME Group by 3.8% in the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after acquiring an additional 39 shares in the last quarter. Finally, Grove Bank & Trust increased its stake in CME Group by 0.8% during the 3rd quarter. Grove Bank & Trust now owns 5,038 shares of the financial services provider’s stock worth $1,320,000 after buying an additional 39 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, CEO Terrence Duffy sold 15,000 shares of the firm’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the sale, the chief executive officer directly owned 40,630 shares in the company, valued at approximately $11,150,497.20. This trade represents a 26.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Elizabeth Cook sold 500 shares of CME Group stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $280.11, for a total value of $140,055.00. Following the sale, the director directly owned 17,916 shares of the company’s stock, valued at approximately $5,018,450.76. The trade was a 2.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 20,900 shares of company stock valued at $5,871,155 in the last 90 days. Company insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $303.14 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $108.50 billion, a P/E ratio of 24.87, a P/E/G ratio of 3.70 and a beta of 0.24. The firm has a 50 day simple moving average of $280.34 and a 200 day simple moving average of $280.01. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.03. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period in the previous year, the company earned $2.68 EPS. Sell-side analysts predict that CME Group Inc. will post 12.34 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th were paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 42.66%.

Analyst Ratings Changes

A number of brokerages have commented on CME. JPMorgan Chase & Co. upgraded CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 target price for the company in a research note on Thursday, October 22nd. Barclays upped their price objective on shares of CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a research note on Thursday, October 22nd. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. UBS Group lifted their price objective on CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a research note on Thursday, October 22nd. Finally, TD Cowen increased their price target on shares of CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a report on Monday, October 5th. Ten equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus price target of $314.44.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.